{"id":"https://openalex.org/W2586986504","doi":"https://doi.org/10.3389/fimmu.2017.00087","title":"In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer","display_name":"In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer","publication_year":2017,"publication_date":"2017-02-06","ids":{"openalex":"https://openalex.org/W2586986504","doi":"https://doi.org/10.3389/fimmu.2017.00087","mag":"2586986504","pmid":"https://pubmed.ncbi.nlm.nih.gov/28220124","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5292674"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2017.00087","doi":"https://doi.org/10.3389/fimmu.2017.00087","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2017.00087","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2017.00087/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2017.00087/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074891444","display_name":"John P. Veluchamy","orcid":"https://orcid.org/0000-0002-5681-1860","observed_orcids":["https://orcid.org/0000-0002-5681-1860"]},"institutions":[{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"John P. Veluchamy","raw_affiliation_strings":["Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, Netherlands; Glycostem Therapeutics, Oss, Netherlands","Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, Netherlands","Glycostem Therapeutics, Oss, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, Netherlands; Glycostem Therapeutics, Oss, Netherlands","institution_ids":["https://openalex.org/I4387152927","https://openalex.org/I911458345"]},{"raw_affiliation_string":"Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4387152927","https://openalex.org/I911458345"]},{"raw_affiliation_string":"Glycostem Therapeutics, Oss, Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077936993","display_name":"Silvia Lopez\u2010Lastra","orcid":"https://orcid.org/0000-0003-2391-6858","observed_orcids":["https://orcid.org/0000-0003-2391-6858"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I157536573","display_name":"Institut Pasteur","ror":"https://ror.org/0495fxg12","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I157536573"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Silvia Lopez-Lastra","raw_affiliation_strings":["Innate Immunity Unit, Institut Pasteur, Paris, France; Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1223, Paris, France; Universit\u00e9 Paris-Sud (Paris-Saclay), Paris, France","Innate Immunity Unit, Institut Pasteur, Paris, France","Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1223, Paris, France","Universit\u00e9 Paris-Sud (Paris-Saclay), Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Innate Immunity Unit, Institut Pasteur, Paris, France; Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1223, Paris, France; Universit\u00e9 Paris-Sud (Paris-Saclay), Paris, France","institution_ids":["https://openalex.org/I102197404","https://openalex.org/I154526488","https://openalex.org/I157536573"]},{"raw_affiliation_string":"Innate Immunity Unit, Institut Pasteur, Paris, France","institution_ids":["https://openalex.org/I157536573"]},{"raw_affiliation_string":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1223, Paris, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Universit\u00e9 Paris-Sud (Paris-Saclay), Paris, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069298631","display_name":"Jan Spanholtz","orcid":"https://orcid.org/0000-0001-7152-6956","observed_orcids":["https://orcid.org/0000-0001-7152-6956"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jan Spanholtz","raw_affiliation_strings":["Glycostem Therapeutics, Oss, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glycostem Therapeutics, Oss, Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079623572","display_name":"Fenna Bohme","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fenna Bohme","raw_affiliation_strings":["Glycostem Therapeutics, Oss, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glycostem Therapeutics, Oss, Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113623967","display_name":"Nina Kok","orcid":"https://orcid.org/0009-0006-6259-6809","observed_orcids":["https://orcid.org/0009-0006-6259-6809"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nina Kok","raw_affiliation_strings":["Glycostem Therapeutics, Oss, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glycostem Therapeutics, Oss, Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057813082","display_name":"Dani\u00eblle A.M. Heideman","orcid":"https://orcid.org/0000-0001-6463-7391","observed_orcids":["https://orcid.org/0000-0001-6463-7391"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Dani\u00eblle A. M. Heideman","raw_affiliation_strings":["Department of Pathology, VU University Medical Center, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, VU University Medical Center, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088673015","display_name":"Henk M.W. Verheul","orcid":"https://orcid.org/0000-0001-5981-922X","observed_orcids":["https://orcid.org/0000-0001-5981-922X","https://orcid.org/0000-0002-2971-247X"]},"institutions":[{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Henk M. W. Verheul","raw_affiliation_strings":["Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4387152927","https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102901793","display_name":"James P. Di Santo","orcid":"https://orcid.org/0000-0002-7146-1862","observed_orcids":["https://orcid.org/0000-0002-7146-1862"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I157536573","display_name":"Institut Pasteur","ror":"https://ror.org/0495fxg12","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I157536573"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"James P. Di Santo","raw_affiliation_strings":["Innate Immunity Unit, Institut Pasteur, Paris, France; Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1223, Paris, France","Innate Immunity Unit, Institut Pasteur, Paris, France","Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1223, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Innate Immunity Unit, Institut Pasteur, Paris, France; Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1223, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I157536573"]},{"raw_affiliation_string":"Innate Immunity Unit, Institut Pasteur, Paris, France","institution_ids":["https://openalex.org/I157536573"]},{"raw_affiliation_string":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1223, Paris, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053105927","display_name":"Tanja D. de Gruijl","orcid":"https://orcid.org/0000-0003-1464-8978","observed_orcids":["https://orcid.org/0000-0003-1464-8978"]},"institutions":[{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Tanja D. de Gruijl","raw_affiliation_strings":["Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4387152927","https://openalex.org/I911458345"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039649967","display_name":"Hans J. van der Vliet","orcid":"https://orcid.org/0000-0001-7846-8613","observed_orcids":["https://orcid.org/0000-0001-7846-8613"]},"institutions":[{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Hans J. van der Vliet","raw_affiliation_strings":["Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4387152927","https://openalex.org/I911458345"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5039649967"],"corresponding_institution_ids":["https://openalex.org/I4387152927","https://openalex.org/I911458345"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":2.4946,"has_fulltext":true,"cited_by_count":53,"citation_normalized_percentile":{"value":0.89347104,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"8","issue":null,"first_page":"87","last_page":"87"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adoptive-nk-cell-therapy","display_name":"adoptive NK cell therapy","score":0.9259999990463257},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9940000176429749},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9330000281333923},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.6940000057220459},{"id":"https://openalex.org/keywords/ras-mutations","display_name":"RAS mutations","score":0.8360000252723694},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":1.0},{"id":"https://openalex.org/keywords/cetuximab-resistance","display_name":"cetuximab resistance","score":0.9459999799728394},{"id":"https://openalex.org/keywords/allogeneic-nk-cells","display_name":"allogeneic NK cells","score":0.7739999890327454},{"id":"https://openalex.org/keywords/nk-cell-cytotoxicity","display_name":"NK cell cytotoxicity","score":0.75},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.546999990940094}],"concepts":[{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.8232334852218628},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6096392273902893},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.5608841180801392},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5500022172927856},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5339120030403137},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5288741588592529},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.4363642632961273},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4134100675582886},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40007761120796204},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37927401065826416},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.26956385374069214},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25465521216392517},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16082656383514404},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.12580618262290955},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.3389/fimmu.2017.00087","doi":"https://doi.org/10.3389/fimmu.2017.00087","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2017.00087","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2017.00087/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4174023","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5292674","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5292674","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5292674","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:28220124","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28220124","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire/33969a8d-0725-4b09-9aad-e8f1d1b3833b","doi":null,"is_oa":true,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/33969a8d-0725-4b09-9aad-e8f1d1b3833b","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Veluchamy, J P, Lopez-Lastra, S, Spanholtz, J, Bohme, F, Kok, N, Heideman, D A M, Verheul, H M W, Di Santo, J P, de Gruijl, T D & van der Vliet, H J 2017, 'In Vivo efficacy of umbilical cord blood stem cell-derived NK cells in the treatment of metastatic colorectal cancer', Frontiers in immunology, vol. 8, no. FEB, 87. https://doi.org/10.3389/fimmu.2017.00087","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/39d136a9-236b-4c8b-87fa-396f58c26449","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/39d136a9-236b-4c8b-87fa-396f58c26449","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, 8(FEB):87. Frontiers Media S.A.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2017.00087","doi":"https://doi.org/10.3389/fimmu.2017.00087","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2017.00087","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2017.00087/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6548269766","display_name":"France Life Imaging","funder_award_id":"ANR-11-INBS-0006","funder_id":"https://openalex.org/F4320320883","funder_display_name":"Agence Nationale de la Recherche"}],"funders":[{"id":"https://openalex.org/F4320320883","display_name":"Agence Nationale de la Recherche","ror":"https://ror.org/00rbzpz17"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2586986504.pdf","grobid_xml":"https://content.openalex.org/works/W2586986504.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W188230809","https://openalex.org/W1491394604","https://openalex.org/W1963939177","https://openalex.org/W1964758348","https://openalex.org/W1966426962","https://openalex.org/W1971222772","https://openalex.org/W1977932880","https://openalex.org/W1981851073","https://openalex.org/W1995338244","https://openalex.org/W2000559031","https://openalex.org/W2000622589","https://openalex.org/W2002761341","https://openalex.org/W2005765588","https://openalex.org/W2008402445","https://openalex.org/W2013224779","https://openalex.org/W2019804037","https://openalex.org/W2019995256","https://openalex.org/W2044103767","https://openalex.org/W2045888711","https://openalex.org/W2073300038","https://openalex.org/W2074826639","https://openalex.org/W2078589933","https://openalex.org/W2082962820","https://openalex.org/W2092215629","https://openalex.org/W2099308699","https://openalex.org/W2103502575","https://openalex.org/W2105003620","https://openalex.org/W2121869934","https://openalex.org/W2122006466","https://openalex.org/W2130649175","https://openalex.org/W2144872368","https://openalex.org/W2146494327","https://openalex.org/W2147787458","https://openalex.org/W2150580086","https://openalex.org/W2150687804","https://openalex.org/W2154497454","https://openalex.org/W2155311724","https://openalex.org/W2155340409","https://openalex.org/W2159717470","https://openalex.org/W2160520392","https://openalex.org/W2163614144","https://openalex.org/W2165155867","https://openalex.org/W2165813814","https://openalex.org/W2235523093","https://openalex.org/W2330713242","https://openalex.org/W2438839873","https://openalex.org/W4246015058"],"related_works":["https://openalex.org/W2724139228","https://openalex.org/W2438839873","https://openalex.org/W2778883508","https://openalex.org/W2462290778","https://openalex.org/W2604024592","https://openalex.org/W2550677391","https://openalex.org/W2585332231","https://openalex.org/W7135562628","https://openalex.org/W2809638941","https://openalex.org/W2892089045"],"abstract_inverted_index":{"Therapeutic":[0],"monoclonal":[1],"antibodies":[2],"(mAbs)":[3],"against":[4,90,197,222],"the":[5,45,50,181,185],"epidermal":[6],"growth":[7],"factor":[8],"receptor":[9],"(EGFR)":[10],"act":[11],"by":[12,18,127,143],"inhibiting":[13],"EGFR":[14,227],"downstream":[15],"signaling":[16],"and":[17,74,95,163,179,189,228],"eliciting":[19],"an":[20,210],"NK":[21,54,64,71,81],"cell-mediated":[22],"anti-tumor":[23,192,220],"response.":[24],"The":[25,191],"IgG1":[26],"mAb":[27],"cetuximab":[28,85,198],"has":[29],"been":[30,234],"used":[31],"for":[32,257],"treatment":[33],"of":[34,52,105,111,118,184,187,194,226,255],"RASwt":[35],"metastatic":[36],"colorectal":[37],"cancer":[38,108,131,174,204,224],"(mCRC)":[39],"patients,":[40],"showing":[41],"limited":[42],"efficacy.":[43],"In":[44],"present":[46],"study":[47],"we":[48],"address":[49],"potential":[51],"adoptive":[53],"cell":[55,65,79],"therapy":[56],"to":[57,102,177],"overcome":[58],"these":[59],"limitations":[60],"investigating":[61],"two":[62],"allogeneic":[63],"products,":[66],"i.e.":[67],"activated":[68],"peripheral":[69],"blood":[70,77],"cells":[72,82,109,132,175,196,205],"(A-PBNK)":[73],"umbilical":[75],"cord":[76],"stem":[78],"derived":[80],"(UCB-NK).":[83],"While":[84],"monotherapy":[86],"was":[87,141,206],"not":[88,121],"effective":[89],"EGFR-":[91],"RASwt,":[92],"EGFR+":[93,96,106,129,154,164,201],"RASmut":[94,155,202],"BRAFmut":[97,165],"cells,":[98],"A-PBNK":[99,119,178,188],"were":[100,123],"able":[101],"initiate":[103],"lysis":[104],"colon":[107,130,173,203,223],"irrespective":[110],"RAS":[112,229],"or":[113],"BRAF":[114],"status.":[115,230],"Cytotoxic":[116],"effects":[117],"(but":[120],"UCB-NK)":[122],"further":[124,207],"potentiated":[125],"significantly":[126,138],"coating":[128],"with":[133],"cetuximab.":[134,190],"Of":[135],"note,":[136],"a":[137,238,249],"higher":[139],"cytotoxicity":[140,221],"induced":[142],"UCB-NK":[144,195,217,232],"in":[145,209,211,237,245],"EGFR-RASwt":[146],"(42":[147],"\u00b1":[148,152,157,161,167,171],"8%":[149],"versus":[150,159,169],"67":[151],"7%),":[153],"(20":[156],"2%":[158],"37":[160],"6%)":[162],"(23":[166],"3%":[168],"43":[170],"7%)":[172],"compared":[176],"equaled":[180],"cytotoxic":[182],"efficacy":[183,193],"combination":[186],"resistant":[199],"human":[200],"confirmed":[208],"vivo":[212],"preclinical":[213],"mouse":[214],"model":[215],"where":[216],"showed":[218],"enhanced":[219],"independent":[225],"As":[231],"have":[233],"proven":[235],"safe":[236],"recently":[239],"conducted":[240],"phase":[241],"I":[242],"clinical":[243,253],"trial":[244],"acute":[246],"myeloid":[247],"leukemia,":[248],"fast":[250],"translation":[251],"into":[252],"proof":[254],"concept":[256],"mCRC":[258],"could":[259],"be":[260],"considered.":[261]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-02-17T00:00:00"}